Keeping Track: Oncology Filings Galore In Run-Up To ASCO Meeting
The latest cancer drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
Keeping Track: Another Gene Therapy Approval, Several Priority Review Designations, And Many Resubmissions
The latest drug development news and highlights from our US FDA Performance Tracker.
FDA Approval Round Up: Keytruda, Opdivo Add Claims
Cancer supplements took center stage for US FDA this week, but OptiNose Inc.'s corticosteroid Xhance also took a bow.
Keeping Track: Oncology Announcements, Priority Review Vouchers Continue To Pile Up
The latest drug development news and US FDA highlights from our Performance Tracker.